CAR-T therapy engineers a patient’s own immune cells to fight cancer. Making these cels more resilient can make treatments more effective.
No comments yet.
Sign in to comment.
Other articles with overlapping topics.
The treatment is shorter and more convenient, but it will not suit every man with prostate cancer.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
A new healthpunk movement aims to teach physicians to use their imaginations The post How to Heal People with Science Fiction appeared first on Nautilus.
This new five-step protocol could make surgery a lot less painful The post The Healing Power of Dreaming Under Anesthesia appeared first on Nautilus.
The post Lawmaker Pushes for Ban on Special Treatment for Convicted Drug Traffickers After ProPublica Report appeared first on ProPublica.
The post A Popular Doctor Had Long Warned That Vitamin K Shots Are Risky for Newborns. Now He’s Changed His Tune. appeared first on ProPublica.